Akebia Therapeutics | AKBA - Umsatzkosten





Umsatzkosten Veränderung Datum
Acadia Pharmaceuticals USD 24.79M 1.43M 2026-03
Agios Pharmaceuticals USD 1.32M 560K 2026-03
Akebia Therapeutics USD 10.34M 441K 2025-12
Alnylam Pharmaceuticals USD 211.12M 56.6M 2026-03
Amgen USD 1.6B 187M 2026-03
Ardelyx USD 10.85M 6.87M 2025-12
Astellas Pharma JPY 129.43B 19.7B 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Bayer EUR 5.23B 731M 2026-03
BioMarin Pharmaceutical USD 199.48M 37.93M 2026-03
Celltrion KRW 107.42B 295.44B 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Exelixis USD 19.95M 6.53M 2026-03
Fresenius Medical Care EUR 3.43B 248M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Ionis Pharmaceuticals USD 3M 5M 2026-03
Ironwood Pharmaceuticals USD 29.83M 560K 2024-09
J&J USD 8.07B 103M 2026-03
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Karyopharm Therapeutics USD 1.48M 35.95M 2025-12
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Lexicon Pharmaceuticals USD 201K 191K 2025-12
Medical Developments International AUD 7.09M 4.91M 2025-12
Moderna USD 955M 503M 2026-03
Nektar Therapeutics USD 4.43M 5.3M 2024-09
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 56.93M 20.53M 2025-12
Pharma Mar EUR 3.66M 116K 2026-03
Prothena USD 28.94M 11.58M 2025-09
PTC Therapeutics USD 39.61M 23.31M 2026-03
Qiagen NV USD 217.43M 29.65M 2025-12
Regeneron Pharmaceuticals USD 669.4M 84.8M 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
Sanofi EUR 3.67B 621M 2026-03
Sarepta Therapeutics USD 109.46M 289.93M 2026-03
Sartorius EUR 484.6M 46.6M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Tilray USD 164.37M 8.41M 2025-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03